The price of Kezar Life Sciences Inc. (NASDAQ: KZR) closed at $4.61 in the last session, down -11.00% from day before closing price of $5.18. In other words, the price has decreased by -$0.5700 from its previous closing price. On the day, 850159 shares were traded. KZR stock price reached its highest trading level at $5.3600 during the session, while it also had its lowest trading level at $4.5400.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Ratios:
We take a closer look at KZR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 31.20 and its Current Ratio is at 31.20. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on December 08, 2021, initiated with a Overweight rating and assigned the stock a target price of $19.
On July 16, 2018, Wells Fargo started tracking the stock assigning a Outperform rating and target price of $30.Wells Fargo initiated its Outperform rating on July 16, 2018, with a $30 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 06 when Morningside Venture Investment sold 40,000 shares for $6.88 per share. The transaction valued at 275,320 led to the insider holds 5,447,993 shares of the business.
Morningside Venture Investment sold 25,000 shares of KZR for $178,650 on Feb 03. The 10% Owner now owns 5,487,993 shares after completing the transaction at $7.15 per share. On Feb 02, another insider, Morningside Venture Investment, who serves as the 10% Owner of the company, sold 50,000 shares for $7.19 each. As a result, the insider received 359,500 and left with 5,512,993 shares of the company.
Stock Price History:
Over the past 52 weeks, KZR has reached a high of $18.55, while it has fallen to a 52-week low of $4.30. The 50-Day Moving Average of the stock is 6.3466, while the 200-Day Moving Average is calculated to be 7.6734.
Shares Statistics:
According to the various share statistics, KZR traded on average about 623.20K shares per day over the past 3-months and 910.36k shares per day over the past 10 days. A total of 72.15M shares are outstanding, with a floating share count of 54.06M. Insiders hold about 1.10% of the company’s shares, while institutions hold 86.30% stake in the company. Shares short for KZR as of Jan 30, 2023 were 4.43M with a Short Ratio of 4.32M, compared to 6.14M on Dec 29, 2022. Therefore, it implies a Short% of Shares Outstanding of 6.46% and a Short% of Float of 7.34%.
Earnings Estimates
The company has 6 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.28 for the current quarter, with a high estimate of -$0.24 and a low estimate of -$0.29, while EPS last year was -$0.25. The consensus estimate for the next quarter is -$0.28, with high estimates of -$0.26 and low estimates of -$0.3.
Analysts are recommending an EPS of between -$1 and -$1.06 for the fiscal current year, implying an average EPS of -$1.04. EPS for the following year is -$1.11, with 6 analysts recommending between -$0.93 and -$1.3.
